Literature DB >> 17629523

Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.

Rodney P DeKoter1, Meghana B Kamath, Isaac B Houston.   

Abstract

The Ets family transcription factor PU.1, encoded by the gene Sfpi1, is essential for normal hematopoiesis. A number of studies have suggested that changes in PU.1 concentration play a role in directing cell fate decisions during hematopoiesis. However, the stages of hematopoietic development at which changes in PU.1 concentration are important have not been defined until recently. Experiments using conditional null alleles, reporter alleles, and hypomorphic alleles of the Sfpi1 gene in mice demonstrate that PU.1 concentration is uniformly high during early stages of hematopoietic development. However, reduction of PU.1 concentration is required for normal development of megakaryocyte-erythroid progenitors, B cell progenitors, and T cell progenitors. PU.1 concentration increases in granulocyte-macrophage progenitors. Furthermore, experimental reduction of PU.1 concentration in the myeloid lineages leads to failed differentiation, abnormal proliferation, and leukemia. In this review, we summarize recent studies to develop a new model of PU.1 function in hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17629523      PMCID: PMC2040501          DOI: 10.1016/j.bcmd.2007.06.004

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  31 in total

1.  Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.

Authors:  Hiromi Iwasaki; Chamorro Somoza; Hirokazu Shigematsu; Estelle A Duprez; Junko Iwasaki-Arai; Shin-Ichi Mizuno; Yojiro Arinobu; Kristin Geary; Pu Zhang; Tajhal Dayaram; Maris L Fenyus; Shannon Elf; Susan Chan; Philippe Kastner; Claudia S Huettner; Richard Murray; Daniel G Tenen; Koichi Akashi
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

Review 2.  Transcription factors in myeloid development: balancing differentiation with transformation.

Authors:  Frank Rosenbauer; Daniel G Tenen
Journal:  Nat Rev Immunol       Date:  2007-02       Impact factor: 53.106

3.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1.

Authors:  R P DeKoter; H Singh
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

4.  Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.

Authors:  Ulrich Steidl; Frank Rosenbauer; Roel G W Verhaak; Xuesong Gu; Alexander Ebralidze; Hasan H Otu; Steffen Klippel; Christian Steidl; Ingmar Bruns; Daniel B Costa; Katharina Wagner; Manuel Aivado; Guido Kobbe; Peter J M Valk; Emmanuelle Passegué; Towia A Libermann; Ruud Delwel; Daniel G Tenen
Journal:  Nat Genet       Date:  2006-10-15       Impact factor: 38.330

5.  The development of functional B lymphocytes in conditional PU.1 knock-out mice.

Authors:  Matthew Polli; Aleksandar Dakic; Amanda Light; Li Wu; David M Tarlinton; Stephen L Nutt
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

6.  PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.

Authors:  Isaac B Houston; Kelly J Huang; Serena R Jennings; Rodney P DeKoter
Journal:  Exp Hematol       Date:  2007-03       Impact factor: 3.084

7.  Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.

Authors:  Frank Rosenbauer; Bronwyn M Owens; Li Yu; Joseph R Tumang; Ulrich Steidl; Jeffery L Kutok; Linda K Clayton; Katharina Wagner; Marina Scheller; Hiromi Iwasaki; Chunhui Liu; Björn Hackanson; Koichi Akashi; Achim Leutz; Thomas L Rothstein; Christoph Plass; Daniel G Tenen
Journal:  Nat Genet       Date:  2005-11-27       Impact factor: 38.330

8.  Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.

Authors:  Isaac B Houston; Meghana B Kamath; Brock L Schweitzer; Timothy M Chlon; Rodney P DeKoter
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

9.  PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis.

Authors:  Aleksandar Dakic; Donald Metcalf; Ladina Di Rago; Sandra Mifsud; Li Wu; Stephen L Nutt
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

10.  PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch.

Authors:  Min Ye; Olga Ermakova; Thomas Graf
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

View more
  22 in total

1.  Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing.

Authors:  Aysegul V Ergen; Nathan C Boles; Margaret A Goodell
Journal:  Blood       Date:  2012-01-30       Impact factor: 22.113

2.  Cell-specific determinants of peroxisome proliferator-activated receptor gamma function in adipocytes and macrophages.

Authors:  Martina I Lefterova; David J Steger; David Zhuo; Mohammed Qatanani; Shannon E Mullican; Geetu Tuteja; Elisabetta Manduchi; Gregory R Grant; Mitchell A Lazar
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

3.  Meeting report: Seventh International Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia, Annapolis, MD, May 13-16, 2007.

Authors:  Linda Wolff; Steven J Ackerman; Giuseppina Nucifora
Journal:  Exp Hematol       Date:  2008-03-04       Impact factor: 3.084

Review 4.  Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation.

Authors:  Tianyu Guo; Xuejun Wang; Yigong Qu; Yu Yin; Tao Jing; Qing Zhang
Journal:  Stem Cell Investig       Date:  2015-02-14

5.  Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation-induced myeloproliferative disease.

Authors:  Karim Iskander; Roberto J Barrios; Anil K Jaiswal
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  PU.1 activation relieves GATA-1-mediated repression of Cebpa and Cbfb during leukemia differentiation.

Authors:  Pavel Burda; Nikola Curik; Juraj Kokavec; Petra Basova; Dana Mikulenkova; Arthur I Skoultchi; Jiri Zavadil; Tomas Stopka
Journal:  Mol Cancer Res       Date:  2009-10-13       Impact factor: 5.852

7.  Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates.

Authors:  Xiaorong Gu; Quteba Ebrahem; Reda Z Mahfouz; Metis Hasipek; Francis Enane; Tomas Radivoyevitch; Nicolas Rapin; Bartlomiej Przychodzen; Zhenbo Hu; Ramesh Balusu; Claudiu V Cotta; David Wald; Christian Argueta; Yosef Landesman; Maria Paola Martelli; Brunangelo Falini; Hetty Carraway; Bo T Porse; Jaroslaw Maciejewski; Babal K Jha; Yogen Saunthararajah
Journal:  J Clin Invest       Date:  2018-07-17       Impact factor: 14.808

8.  Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.

Authors:  Carole Le Coz; David N Nguyen; Chun Su; Brian E Nolan; Amanda V Albrecht; Suela Xhani; Di Sun; Benjamin Demaree; Piyush Pillarisetti; Caroline Khanna; Francis Wright; Peixin Amy Chen; Samuel Yoon; Amy L Stiegler; Kelly Maurer; James P Garifallou; Amy Rymaszewski; Steven H Kroft; Timothy S Olson; Alix E Seif; Gerald Wertheim; Struan F A Grant; Linda T Vo; Jennifer M Puck; Kathleen E Sullivan; John M Routes; Viktoria Zakharova; Anna Shcherbina; Anna Mukhina; Natasha L Rudy; Anna C E Hurst; T Prescott Atkinson; Titus J Boggon; Hakon Hakonarson; Adam R Abate; Joud Hajjar; Sarah K Nicholas; James R Lupski; James Verbsky; Ivan K Chinn; Michael V Gonzalez; Andrew D Wells; Alex Marson; Gregory M K Poon; Neil Romberg
Journal:  J Exp Med       Date:  2021-05-05       Impact factor: 14.307

9.  PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1.

Authors:  Daniel E Foxler; Victoria James; Samuel J Shelton; Thomas Q de A Vallim; Peter E Shaw; Tyson V Sharp
Journal:  FEBS Lett       Date:  2011-03-12       Impact factor: 4.124

10.  The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice.

Authors:  Theresa J Barberi; Alexis Dunkle; You-Wen He; Luigi Racioppi; Anthony R Means
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.